Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN13642102Phase 4Completed
Phase 4, randomised, open-label trial of dexmedetomidine, propofol and midazolam in None (2 arms), sponsored by University of Crete. Primary endpoints: Postoperative delirium, Postoperative cognitive dysfunction and 2 more. Started May 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN13642102.